Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Letrozole 36 Fulvestrant 32 Specimen Handling 30 ribociclib 23 pembrolizumab 23 Paclitaxel 23 palbociclib 20 Trastuzumab 20 Magnetic Resonance Spectroscopy 20 Carboplatin 19 Anastrozole 19 exemestane 18 Capecitabine 18 abemaciclib 16 Biopsy 16 pertuzumab 15 Tamoxifen 15 trastuzumab deruxtecan 12 Cyclophosphamide 10 Taxes 9 Radiotherapy 9 Goserelin 9 Docetaxel 8 giredestrant 7 elacestrant 7 Standard of Care 7 130-nm albumin-bound paclitaxel 7 inavolisib 6 eribulin 6 atezolizumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FAPI-46 × Breast × 30 days × Clear all

NCT06540872 2026-06-03

MI-CISDIR

Universität Münster

Phase 2 Recruiting

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡